Journals / Sabuncuoglu Serefeddin Health Sciences / 2023 / Cilt: 5 Sayı: 1

EVALUATION OF THE RATE OF HEPATITIS A IMMUNITY IN A SMALL CITY AFTER THE VACCINATION PROGRAM: ONE CENTER EXPERIENCE

Pages
60–72
Publication Date
2023-05-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Overall 1189 children aged 1-17 years old enrolled to the study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Hepatitis A is an infectious disease caused by hepatitis A virus (HAV).
📊
Key Findings & Data:The aim of this study is to determine the rate of immunity against HAV infection in a sample of pediatric population.
💡
Conclusion & Impact:Results: Overall 1189 children aged 1-17 years old enrolled to the study.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Hepatitis A · Natural immunity · Seroprevalance

Abstract

Purpose: Hepatitis A is an infectious disease caused by hepatitis A virus (HAV). Symptomatic infection causes health care costs with loss of labor and school time. HAV outbreaks may cause economic problems by disrupting trade and tourism. The aim of this study is to determine the rate of immunity against HAV infection in a sample of pediatric population. Methods: The study group consisted of all children who underwent anti-HAV IgG evaluation for any reason between January 1, 2012 and December 31, 2020. The data about age, date of birth, sex, residence, vaccination status were retrospectively collected from the hospital record system. Anti-HAV IgG status was determined by chemiluminescent microparticle immunassay kits. The statistical analyses were presented with descriptive methods. Results: Overall 1189 children aged 1-17 years old enrolled to the study. The rate of anti HAV IgG seropositivity was 41.2% in the whole study group. The rates of completed vaccination scheme and seropositivity were 10.7% and 92.2%. Natural immunity rate was 32.6%. Conclusion: The 7-17 age group was found to be susceptible to the acute infection, they were considered as the new target population of vaccination. Vaccination seemed to be the most effective way of providing seropositivity to get rid of acute infection risk and eliminating geographic and socioeconomic differences.

🔖

Cite This Article

CELEP, G., ÖZÇELİK, H. B., EVSİLE, S. (2023). EVALUATION OF THE RATE OF HEPATITIS A IMMUNITY IN A SMALL CITY AFTER THE VACCINATION PROGRAM: ONE CENTER EXPERIENCE. Sabuncuoglu Serefeddin Health Sciences, Cilt: 5 Sayı: 1, 60–72. https://ajindex.com/articles/938006

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Askling, H. H., Rombo, L., Andersson, Y., Martin, S., & Ekdahl, K. (2009). Hepatitis A risk in travelers. Journal of travel medicine, 16(4), 233-238.
  2. Carrillo-Santisteve, P., Tavoschi, L., Severi, E., Bonfigli, S., Edelstein, M., Byström, E., Dominguez, A. (2017). Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. The Lancet Infectious Diseases, 17(10), e306- e319. Ciocca, M. (2000). Clinical course and consequences of hepatitis A infection. Vaccine, 18, S71-S74. Control, E. C. f. D. P. a. (2014). Food-and waterborne diseases and zoonoses Annual epidemiological report. Retrieved June 2022, from http://ecdc.europa.eu/en/publications/Publications/food-waterborne-diseases-annualepidemiological-report-2014.pdf
  3. Dawid, H. (2008). Control of Communicable Diseases Mannual; Hepatitis A (H. Dawid Ed. 18 ed.). Washington DC: American Public Health Association. Demiray, T., Köroğlu, M., Jacobsen, K. H., Özbek, A., Terzi, H. A., & Altındiş, M. (2016). Hepatitis A virus epidemiology in Turkey as universal childhood vaccination begins: seroprevalence and endemicity by region. The Turkish Journal of Pediatrics, 58(5), 480. Derya, D., Necmi, A., Emre, A., & Akgun, Y. (2005). Decline of maternal hepatitis A antibodies during the first 2 years of life in infants born in Turkey. American Journal of Tropical Medicine and Hygiene, 73(2). Garcia-Comas, L., Ordobas, M., Sanz, J. C., Ramos, B., Arce, A., & Barranco, D. (2016). Population study of seroprevalence of antibodies against hepatitis A virus in the Community of Madrid, 2008-2009. Enfermedades infecciosas y microbiologia clinica, 34(1), 33-38.
  4. Guzelkucuk, Z., Camurdan, A. D., Beyazova, U., Bozdayı, G., Civil, F., & Kocak, A. A. (2019). Waning Time of Maternally Derived Anti-Hepatitis A and Anti-Varicella Zoster Virus Antibodies. Journal of Pediatric Infectious Diseases, 14(03), 116-120.
  5. Jacobsen, K., & Koopman, J. (2005). The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. International journal of epidemiology, 34(3), 600- 609. Jacobsen, K. H. (2009). The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. Jacobsen, K. H., & Wiersma, S. T. (2010). Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine, 28(41), 6653-6657.
  6. Kader, Ç., Göçmen, A. Y., Demir, M. I., Çolak, N. Y., Gök, S. E., Arıkan, F. İ.,. Erbay, A. (2019). Hepatitis A immunity in